Russia Pharmacovigilance Market Outlook (2018 to 2032)

Year Value
2018 124.84
2019 132.37
2020 140.35
2021 148.99
2022 158.15
2023 168.01
2024 178.49
2025 189.63
2026 201.46
2027 214.03
2028 228.71
2029 244.4
2030 261.16
2031 284.22
2032 309.32
  • To Get Uninterrupted Charts Access Please Subscribe
  • Dedicated Client Service Manager
  • Dedicated Analyst Support
  • View access to 2 million data
Russia Pharmacovigilance Market Outlook (2018 to 2032)

Synopsis
The above chart is Russia Pharmacovigilance Market Outlook (2018 to 2032)

Market Dynamics

pharmacovigilance is the process of monitoring the safety of drugs and other pharmacological agents after they have been placed into the market. as the global pharmaceutical industry continues to grow, more attention is being paid to pharmacovigilance in order to ensure that drugs are safe and effective throughout their lifecycle. in russia, pharmacovigilance is regulated by the federal service for surveillance in healthcare and social development (roszdravnadzor). this organization is responsible for taking appropriate action when adverse reactions or events occur with regard to the use of therapeutic products. the majority of adverse events are tracked through the national register of adverse drug reactions (narep). narep stores the data sets collected from adverse event reporting (aer) from the healthcare sector and the pharmaceutical industry. aers must be reported to roszdravnadzor within 24 hours of the occurrence of the adverse event. roszdravnadzor is also responsible for evaluating and approving pharmacovigilance plans submitted by pharmaceutical companies before they can place a drug on the russian market. these plans must include safety surveillance activities, risk minimization measures, and communication of safety information to healthcare professionals. it is also important for pharmaceutical companies to comply with regulatory requirements for submitting updated periodic safety reports to monitor potential safety issues and evaluate the risk-benefit profile of the drug. in terms of the pharmacovigilance market outlook in russia, the increasing demand for drugs and the awareness of drug safety is a key driver of the overall market. this is expected to remain a key factor in the growth of the market in the years to come. it is important for the government to continuously improve the regulatory environment in order to ensure safe drugs are available in the market. this will also create a strong market for pharma companies to abide by the pharmacovigilance regulations which will consequently help to ensure the safety of the population.

Further Content:You might find this interesting as well

Industries List

OTHER STATISTICS ON THE TOPIC

No Simillar Charts
SINGLE SEAT SOLUTIONS FOR INDIVIDUALS AND SMALL BUSINESSES
Efficient research: Relevant data available at a click

Starter Account

$49 USD/month

* Billed Annually

  • Download XLS, PNG & PPT
  • View Access to 1 Million Data
  • View Access to Entire Platform

Single User Account

$599 USD/month

* Billed Annually

  • Dedicated Client Service Manager
  • Download XLS, PNG & PPT
  • View access to 2 million data
  • View Access to Entire Platform

Business Account

$899 USD/month

* Billed Annually

  • Dedicated Client Service Manager
  • Dedicated Analyst Support
  • Suggestive request box to accommodate new markets during subscription period
  • Access to the entire data & statistics with download rights for up to 10000 Premium statistics per 12 months without publication rights
  • View Access to Entire Platform
CONTACT

Closebutton

Stay Ahead with Exclusive Data!

Subscribe Now to Access Our Market Research Platform,and Charts
for B2B and B2C Industries. Empower Your Business with Insights